Read the latest positive news, breakthroughs, and inspiring stories about endometrial cancer, curated daily by BrightWire.
A breakthrough cancer treatment just became the first drug to outperform traditional chemotherapy for a common women's cancer. The results could change how thousands of patients are treated starting now.
A breakthrough treatment for aggressive endometrial cancer significantly extended survival in clinical trials, offering hope for patients who've run out of options. This marks the first time any drug of its kind has outperformed chemotherapy for this increasingly deadly cancer.
A groundbreaking clinical trial shows a new treatment significantly extends survival for women with advanced endometrial cancer who have exhausted other options. This marks the first global success for this type of drug in treating one of the few cancers growing deadlier worldwide.
Women taking Ozempic-type drugs with hormone therapy slashed their uterine cancer risk by two-thirds compared to hormones alone. The discovery could spare thousands from surgery and offer new protection against the most common gynecologic cancer.